I

InBody Co Ltd
KOSDAQ:041830

Watchlist Manager
InBody Co Ltd
KOSDAQ:041830
Watchlist
Price: 26 050 KRW 1.36% Market Closed
Market Cap: 351.2B KRW
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

Price Targets Summary
InBody Co Ltd

Wall Street analysts forecast InBody Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for InBody Co Ltd is 35 700 KRW with a low forecast of 35 350 KRW and a high forecast of 36 750 KRW.

Lowest Forecast
Wall Street Target
35 350 KRW
36% Upside
Average Forecast
Wall Street Target
35 700 KRW
37% Upside
Highest Forecast
Wall Street Target
36 750 KRW
41% Upside
Lowest
Price Target
35 350 KRW
36% Upside
Average
Price Target
35 700 KRW
37% Upside
Highest
Price Target
36 750 KRW
41% Upside
InBody Co Ltd Competitors:
Price Targets
NPCE
Neuropace Inc
36% Upside
EMBLA
Embla Medical hf
1% Upside
BDX
Becton Dickinson and Co
29% Upside
B
BIOBV
Biohit Oyj
20% Upside
NPCE
Neuropace Inc
36% Upside
EMBLA
Embla Medical hf
1% Upside
BDX
Becton Dickinson and Co
29% Upside
B
BIOBV
Biohit Oyj
20% Upside
S
605186
Shanghai General Healthy Information and Technology Co Ltd
9% Upside
BSX
Boston Scientific Corp
20% Upside
2235
MicroTech Medical Hangzhou Co Ltd
12% Downside
V
100120
Vieworks Co Ltd
42% Upside

Revenue
Forecast

Revenue Estimate
InBody Co Ltd

For the last 13 years the compound annual growth rate for InBody Co Ltd's revenue is 15%. The projected CAGR for the next 2 years is 13%.

15%
Past Growth
13%
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
InBody Co Ltd

For the last 13 years the compound annual growth rate for InBody Co Ltd's operating income is 19%. The projected CAGR for the next 2 years is 15%.

19%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-7%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
InBody Co Ltd

For the last 13 years the compound annual growth rate for InBody Co Ltd's net income is 15%. The projected CAGR for the next 2 years is 14%.

15%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is InBody Co Ltd's stock price target?
Price Target
35 700 KRW

According to Wall Street analysts, the average 1-year price target for InBody Co Ltd is 35 700 KRW with a low forecast of 35 350 KRW and a high forecast of 36 750 KRW.

What is InBody Co Ltd's Revenue forecast?
Projected CAGR
13%

For the last 13 years the compound annual growth rate for InBody Co Ltd's revenue is 15%. The projected CAGR for the next 2 years is 13%.

What is InBody Co Ltd's Operating Income forecast?
Projected CAGR
15%

For the last 13 years the compound annual growth rate for InBody Co Ltd's operating income is 19%. The projected CAGR for the next 2 years is 15%.

What is InBody Co Ltd's Net Income forecast?
Projected CAGR
14%

For the last 13 years the compound annual growth rate for InBody Co Ltd's net income is 15%. The projected CAGR for the next 2 years is 14%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 261,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.